Skip to main content
Clinical Trials/NCT03929952
NCT03929952
Completed
Not Applicable

Descriptive Pilot Study of the Effects of a Standardized Neuromodulation Program on Cortical Brain Function in Chronic Low Back Pain Patients

Centre Hospitalier Universitaire de Nīmes1 site in 1 country15 target enrollmentJanuary 19, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Low Back Pain
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
15
Locations
1
Primary Endpoint
Description of the cortical zone activated by neurofeedback
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study aims to evaluate neurofeedback-induced changes in brain function and the correlations between these changes and clinical scores by functional magnetic resonance imaging and electroencephalography in patients with low back pain.

Registry
clinicaltrials.gov
Start Date
January 19, 2022
End Date
October 25, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient with a wifi connexion at home
  • Patient with the ability to modulate the height of the candle by thinking in the alpha synchrony test.
  • Patient with chronic low back pain for more than six months with a visual analogue pain scale greater than 5 impacting activities of daily living, hobbies and work
  • Patient having given free and informed consent and signed consent.
  • Affected patient or beneficiary of a health insurance plan.
  • Patient who is at least 18 years old (≥) and younger than 75 years old (\<).

Exclusion Criteria

  • Pregnant or breastfeeding patient
  • Patient with a contraindication to performing a fMRI scan: ferromagnetic implant in the body, piercing, claustrophobia, unable to remain in the scanner stationary for 40 minutes
  • Patient already included in another study
  • Patient in a exclusion period determined by a previous study
  • The subject is under the protection of justice, guardianship or curatorship.
  • The subject refuses to sign the consent.
  • It is not possible to give the subject informed information.

Outcomes

Primary Outcomes

Description of the cortical zone activated by neurofeedback

Time Frame: Day 20

Measure taken by electroencephalography

Secondary Outcomes

  • Fear Avoidance Beliefs Questionnaire (FABQ)(Day 20)
  • Back Beliefs Questionnaire (BBQ)(Day 20)
  • Oswestry Disability Index (ODI)(Day 20)
  • Coping Strategies Questionnaire (CSQ)(Day 20)
  • Scale of lumbar pain in Quebec(Day 20)
  • Tampa scale(Day 20)
  • Hospital Anxiety and Depression Scale (HADS)(Day 20)

Study Sites (1)

Loading locations...

Similar Trials